OSUR: OraSure Projected Price to Earnings

OSUR (OraSure Technologies) - company brandmark

Price action on GURU.Markets for OraSure Technologies (OSUR), a leader in the rapid testing and biospecimen collection segment, shows a P/E ratio of 0.00. The business relies on the accessibility of home and clinical genetic diagnostics. Current success is based on cost optimization following a decline in demand for COVID-19 tests, while existing cash reserves ensure the company's financial stability.

Market Cap to Projected Earnings: orasure.com (OSUR) for 07/04/2022 - 11/14/2026

Analytical breakdowns and data insights for company OraSure Corp (OSUR)

- stock value and consensus price forecast:
Analysis of all company metrics:OSUR OraSure
Signature product of OraSure Technologies

Professional capital evaluates OraSure Technologies (OSUR) through the lens of future earnings. The forward P/E ratio relates the current share price to projected net income, determining the cost of one dollar of profit. By analyzing the company's current expected P/E, an investor can identify the balance between overpayment and growth rates. Environmental production optimization and plastic recycling reduce costs, supporting fundamental value. This makes the asset more resilient.

Direct competitors

Future Price to Earnings Agilent (A)|Future Price to Earnings DGX (Quest Diagnostics Inc.)|Illumina Corp - Projected Price to Earnings|Exact Sciences Inc. (EXAS) - Projected Price to Earnings Ratio|RVTY - Future Price to Earnings|Market Cap to Projected Earnings bio-rad.com BIO|NNNN: Forward P/E Multiple|SHC - Market Cap to Projected Earnings|Future Price to Earnings QuidelOrtho Corp|OPKO Health Corp. (OPK) - Market Cap to Projected Earnings|Future Price to Earnings CareDx (CDNA)|MRVI - Projected Price to Earnings Ratio|Future Price to Earnings Fulgent Genetics FLGT|Future Price to Earnings Multiple LAB|Cytek Bio - Forward P/E Multiple|XGN - Forward P/E Multiple|MDxHealth SA (MDXH) - Future Price to Earnings|LUCD - Market Cap to Projected Earnings|Projected Price to Earnings PRE|Forward P/E Multiple Insight Molecular|Future Price to Earnings Trinity Biotech plc (TRIB)|PRPH (ProPhase Labs Corp) - Future Price to Earnings Multiple|Forward P/E Multiple AIMD (Ainos, Inc.)|codiagnostics.com (CODX) - Projected Price to Earnings Ratio|HSCS: Projected Price to Earnings|Future Price to Earnings Multiple BMRA (Biomerica Inc.)|CDIO (cardiodiagnosticsinc.com) - Projected Price to Earnings|ONCO: Market Cap to Future Earnings Ratio|VRAX (Virax Biolabs Group) - Forward P/E Multiple|Projected Price to Earnings Ratio bluejaydx.com BJDX|Forward P/E Multiple AWH|Projected Price to Earnings Accelerate Diagnostics Inc. AXDX|Forward P/E Multiple CNTG (CENTOGENE N.V.)|Future Price to Earnings Multiple ENZ|FRES - Future Price to Earnings|GENE (Genetic Technologies) - Price to Future Earnings Ratio|23andMe (ME) - Future Price to Earnings|Projected Price to Earnings Ratio Psychemedics Corp. (PMD)